CNMD vs NOC · P/E 19, rev $1.37B vs P/E 17, rev $20.76B
CONMED Corporation (CNMD) versus Northrop Grumman Corporation (NOC) — a side-by-side from cached financials, not a winner call.
CONMED Corporation (CNMD) is a medical devices company listed on NYSE.
Northrop Grumman Corporation (NOC) is a aerospace & defense company listed on NYSE.
Latest reported CNMD revenue for 2025-12-31 was $1.37B. Net income was $47.1M. Revenue was up 5.2% from 2024-12-31 to 2025-12-31. CNMD currently screens at market cap $1.04B and trailing P/E 19.3.
Latest reported NOC revenue for 2026-06-30 was $20.76B. Net income was $1.97B. NOC currently screens at market cap $78.14B and trailing P/E 17.2.
CNMD currently screens at market cap $1.04B and trailing P/E 19.3. NOC currently screens at market cap $78.14B and trailing P/E 17.2.
Not investment advice. Open the CNMD and NOC stock pages for the full models.
Not investment advice.